Theracryf Income Statement

Financials in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2015 - 2019
Revenue	-	0.4	0.44	-	0.19	-	Upgrade
Revenue Growth (YoY)	-	-10.41%	-	-	-	-	Upgrade
Cost of Revenue	3.34	3.95	5.53	3.18	3.39	3.14	Upgrade
Gross Profit	-3.34	-3.55	-5.09	-3.18	-3.2	-3.14	Upgrade
Selling, General & Admin	0.02	0.02	0.01	0.01	0.02	0.03	Upgrade
Operating Expenses	0.02	0.02	0.01	0.01	0.02	0.03	Upgrade
Operating Income	-3.36	-3.57	-5.1	-3.19	-3.21	-3.17	Upgrade
Interest & Investment Income	0.01	-	0.1	0.02	-	-	Upgrade
EBT Excluding Unusual Items	-3.35	-3.57	-5.01	-3.17	-3.21	-3.17	Upgrade
Pretax Income	-3.35	-3.57	-5.01	-3.17	-3.21	-3.17	Upgrade
Income Tax Expense	-0.43	-0.43	-0.96	-0.44	-0.54	-0.45	Upgrade
Net Income	-2.92	-3.14	-4.04	-2.73	-2.67	-2.72	Upgrade
Net Income to Common	-2.92	-3.14	-4.04	-2.73	-2.67	-2.72	Upgrade
Shares Outstanding (Basic)	349	275	275	275	147	129	Upgrade
Shares Outstanding (Diluted)	349	275	275	275	147	129	Upgrade
Shares Change (YoY)	27.13%	-	-	86.97%	13.69%	34.90%	Upgrade
EPS (Basic)	-0.01	-0.01	-0.01	-0.01	-0.02	-0.02	Upgrade
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01	-0.02	-0.02	Upgrade
Free Cash Flow	-3.11	-3	-4.13	-2.59	-2.93	-2.58	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.02	-0.02	Upgrade
Operating Margin	-	-900.51%	-1154.75%	-	-1656.19%	-	Upgrade
Profit Margin	-	-792.17%	-914.71%	-	-1378.35%	-	Upgrade
Free Cash Flow Margin	-	-756.57%	-933.94%	-	-1510.83%	-	Upgrade
EBITDA	-3.32	-3.56	-5.09	-3.18	-3.2	-3.15	Upgrade
D&A For EBITDA	0.04	0.01	0.01	0.02	0.02	0.02	Upgrade
EBIT	-3.36	-3.57	-5.1	-3.19	-3.21	-3.17	Upgrade

Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.